Oppenheimer Assumes Portage Biotech inc. (PRTG) at Outperform

July 18, 2022 9:17 AM EDT Send to a Friend
Oppenheimer analyst Matthew Biegler assumes coverage on Portage Biotech inc. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login